These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 946143)
1. The interaction of growth hormone, somatomedin and oestrogen in patients with Turner's syndrome. Saenger P; Schwartz E; Wiedemann E; Levine LS; Tsai M; New MI Acta Endocrinol (Copenh); 1976 Jan; 81(1):9-18. PubMed ID: 946143 [TBL] [Abstract][Full Text] [Related]
2. Immunoreactive somatomedin B in acromegaly and in Turner's syndrome. Benker G; Spira G; Zäh W; Tharandt L; Hackenberg K; Reinwein D Clin Endocrinol (Oxf); 1979 Oct; 11(4):357-65. PubMed ID: 519875 [TBL] [Abstract][Full Text] [Related]
3. Growth in Turner's syndrome: long term treatment with low dose ethinyl estradiol. Martínez A; Heinrich JJ; Domené H; Escobar ME; Jasper H; Montuori E; Bergadá G J Clin Endocrinol Metab; 1987 Aug; 65(2):253-7. PubMed ID: 3597706 [TBL] [Abstract][Full Text] [Related]
4. Specific, time-dependent actions of low-dose ethinyl estradiol administration on the episodic release of growth hormone, follicle-stimulating hormone, and luteinizing hormone in prepubertal girls with Turner's syndrome. Mauras N; Rogol AD; Veldhuis JD J Clin Endocrinol Metab; 1989 Nov; 69(5):1053-8. PubMed ID: 2507569 [TBL] [Abstract][Full Text] [Related]
6. Effects of acute high dose and chronic low dose estrogen on plasma somatomedin-C and growth in patients with Turner's syndrome. Copeland KC J Clin Endocrinol Metab; 1988 Jun; 66(6):1278-82. PubMed ID: 3372687 [TBL] [Abstract][Full Text] [Related]
7. Serum thymidine activity and somatomedin-C levels in children and adolescents with Turner's syndrome: effect of chronic estrogen and progestogen replacement therapy. Guidoux S; Bozzola M; Larizza D; Schimpff RM Horm Res; 1986; 24(4):256-62. PubMed ID: 3781484 [TBL] [Abstract][Full Text] [Related]
8. Growth hormone secretion in Turner's syndrome and influence of oxandrolone and ethinyl oestradiol. Massarano AA; Brook CG; Hindmarsh PC; Pringle PJ; Teale JD; Stanhope R; Preece MA Arch Dis Child; 1989 Apr; 64(4):587-92. PubMed ID: 2751332 [TBL] [Abstract][Full Text] [Related]
9. Growth hormone treatment in girls with Turner's syndrome. A review of the literature. Wilton P Acta Paediatr Scand; 1987 Mar; 76(2):193-200. PubMed ID: 3296625 [TBL] [Abstract][Full Text] [Related]
10. Testosterone-estradiol-binding globulin in patients with Turner's syndrome: effects of estrogens and acute growth hormone administration. Bergink EW; Wolf DL; Wittliff JL; Bruining GJ; Bryson MF; Forbes GB J Clin Endocrinol Metab; 1976 Jun; 42(6):1018-23. PubMed ID: 180042 [TBL] [Abstract][Full Text] [Related]
11. Growth hormone therapy for patients with Turner's syndrome. Singer-Granick C; Lee PA; Foley TP; Becker DJ Horm Res; 1986; 24(4):246-50. PubMed ID: 3781482 [TBL] [Abstract][Full Text] [Related]
12. Twenty-four hour plasma GH, FSH and LH profiles in patients with Turner's syndrome. Villadolid MC; Takano K; Hizuka N; Asakawa K; Sukegawa I; Horikawa R; Shizume K Endocrinol Jpn; 1988 Feb; 35(1):71-81. PubMed ID: 3135180 [TBL] [Abstract][Full Text] [Related]
13. Decreased growth hormone response to growth hormone-releasing hormone in Turner's syndrome: relation to body weight and adiposity. Reiter JC; Craen M; Van Vliet G Acta Endocrinol (Copenh); 1991 Jul; 125(1):38-42. PubMed ID: 1872123 [TBL] [Abstract][Full Text] [Related]
14. Effects of luteinizing hormone-releasing hormone (LRH) upon bioactive and immunoreactive serum LH in patients with Turner's syndrome before and after oestrogen treatment. Celani MF; Montanini V; Marrama P Acta Endocrinol (Copenh); 1985 Jul; 109(3):304-8. PubMed ID: 3895799 [TBL] [Abstract][Full Text] [Related]
15. Serum growth hormone (GH)-binding protein and insulin-like growth factor-I levels in Turner's syndrome before and during treatment with recombinant human GH and ethinyl estradiol. Massa G; Bouillon R; Vanderschueren-Lodeweyckx M J Clin Endocrinol Metab; 1992 Nov; 75(5):1298-302. PubMed ID: 1430092 [TBL] [Abstract][Full Text] [Related]
16. Improved final height in girls with Turner's syndrome treated with growth hormone and oxandrolone. Nilsson KO; Albertsson-Wikland K; Alm J; Aronson S; Gustafsson J; Hagenäs L; Häger A; Ivarsson SA; Karlberg J; Kriström B; Marcus C; Moell C; Ritzen M; Tuvemo T; Wattsgård C; Westgren U; Westphal O; Aman J J Clin Endocrinol Metab; 1996 Feb; 81(2):635-40. PubMed ID: 8636281 [TBL] [Abstract][Full Text] [Related]
17. Growth hormone and somatomedin C during post-menopausal replacement therapy with oestrogen alone and in combination with an antioestrogen. Fröhlander N; von Schoultz B Maturitas; 1988 Mar; 9(4):297-302. PubMed ID: 3380016 [TBL] [Abstract][Full Text] [Related]
18. Effect of obesity on endogenous secretion of growth hormone in Turner's syndrome. Lu PW; Cowell CT; Jimenez M; Simpson JM; Silink M Arch Dis Child; 1991 Oct; 66(10):1184-90. PubMed ID: 1953000 [TBL] [Abstract][Full Text] [Related]
19. Somatomedin A in human serum, determined by radioreceptor assay. Takano K; Hall K; Ritzén M; Iselius L; Sievertsson H Acta Endocrinol (Copenh); 1976 Jul; 82(3):449-59. PubMed ID: 947120 [TBL] [Abstract][Full Text] [Related]